One year after ICU admission for severe community-acquired pneumonia of bacterial, viral or unidentified etiology. What are the outcomes?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 01 04 2020
accepted: 29 11 2020
entrez: 14 12 2020
pubmed: 15 12 2020
medline: 3 2 2021
Statut: epublish

Résumé

Multiplex polymerase chain reaction (mPCR) for respiratory virus testing is increasingly used in community-acquired pneumonia (CAP), however data on one-year outcome in intensive care unit (ICU) patients with reference to the causative pathogen are scarce. We performed a single-center retrospective study in 123 ICU patients who had undergone respiratory virus testing for CAP by mPCR and with known one-year survival status. Functional status including dyspnea (mMRC score), autonomy (ADL Katz score) and need for new home-care ventilatory support was assessed at a one-year post-ICU follow-up. Mortality rates and functional status were compared in patients with CAP of a bacterial, viral or unidentified etiology one year after ICU admission. The bacterial, viral and unidentified groups included 19 (15.4%), 37 (30.1%), and 67 (54.5%) patients, respectively. In multivariate analysis, one-year mortality in the bacterial group was higher compared to the viral group (HR 2.92, 95% CI 1.71-7.28, p = 0.02) and tended to be higher compared to the unidentified etiology group (p = 0.06); but no difference was found between the viral and the unidentified etiology group (p = 0.43). In 64/83 one-year survivors with a post-ICU follow-up consultation, there were no differences in mMRC score, ADL Katz score and new home-care ventilatory support between the groups (p = 0.52, p = 0.37, p = 0.24, respectively). Severe dyspnea (mMRC score = 4 or death), severe autonomy deficiencies (ADL Katz score ≤ 2 or death), and major adverse respiratory events (new home-care ventilatory support or death) were observed in 52/104 (50.0%), 47/104 (45.2%), and 65/104 (62.5%) patients, respectively; with no difference between the bacterial, viral and unidentified group: p = 0.58, p = 0.06, p = 0.61, respectively. CAP of bacterial origin had a poorer outcome than CAP of viral or unidentified origin. At one-year, impairment of functional status was frequently observed, with no difference according to the etiology.

Identifiants

pubmed: 33315946
doi: 10.1371/journal.pone.0243762
pii: PONE-D-20-09347
pmc: PMC7735561
doi:

Banques de données

Dryad
['10.5061/dryad.vx0k6djpc']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0243762

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Respir Med. 2010 Jun;104(6):773-9
pubmed: 20417082
Stat Med. 2008 Jan 15;27(1):36-46
pubmed: 17634969
J Cardiothorac Vasc Anesth. 2019 Jan;33(1):72-79
pubmed: 30049521
J Infect. 2014 Jun;68(6):534-41
pubmed: 24534605
Crit Care. 2015 Oct 02;19:356
pubmed: 26428615
Respiration. 2016;92(5):286-294
pubmed: 27649510
Acta Anaesthesiol Scand. 2011 Nov;55(10):1254-60
pubmed: 22092131
Intensive Care Med. 2019 Feb;45(2):159-171
pubmed: 30706119
Am J Respir Crit Care Med. 2002 Sep 1;166(5):717-23
pubmed: 12204871
Curr Opin Crit Care. 2018 Feb;24(1):35-40
pubmed: 29189296
JAMA. 2010 Oct 27;304(16):1787-94
pubmed: 20978258
Ann Intensive Care. 2018 Aug 15;8(1):84
pubmed: 30112650
PLoS One. 2016 Feb 05;11(2):e0148741
pubmed: 26849359
JAMA. 1999 Jan 27;281(4):354-60
pubmed: 9929089
J Crit Care. 2015 Aug;30(4):721-6
pubmed: 25818842
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Crit Care. 2014 Apr 01;18(2):R58
pubmed: 24690444
Intensive Care Med. 2006 Jul;32(7):1022-9
pubmed: 16791664
Chest. 2012 Sep;142(3):583-592
pubmed: 22948576
Crit Care Med. 2003 May;31(5):1373-81
pubmed: 12771605
Br Med J. 1959 Aug 29;2(5147):257-66
pubmed: 13823475
J Clin Virol. 2017 Jul;92:48-51
pubmed: 28527970
Crit Care. 2011;15(5):R209
pubmed: 21914220
PLoS One. 2016 Jan 04;11(1):e0145929
pubmed: 26727202
Am J Respir Crit Care Med. 2012 Aug 15;186(4):325-32
pubmed: 22700859
Stat Med. 2003 Apr 15;22(7):1069-82
pubmed: 12652554
Stat Med. 2007 Aug 15;26(18):3385-97
pubmed: 17149799
Eur J Clin Microbiol Infect Dis. 2013 May;32(5):705-10
pubmed: 23274861
Chest. 2005 Dec;128(6):3810-6
pubmed: 16354849
Curr Opin Crit Care. 2018 Dec;24(6):531-539
pubmed: 30239410
Infect Dis Clin North Am. 2009 Sep;23(3):503-20
pubmed: 19665080
Lancet. 2015 Sep 12;386(9998):1097-108
pubmed: 26277247
Clin Infect Dis. 2014 Jul 1;59(1):62-70
pubmed: 24729498
N Engl J Med. 2003 Feb 20;348(8):683-93
pubmed: 12594312
PLoS One. 2018 Jan 25;13(1):e0191721
pubmed: 29370285
Chest. 2010 Mar;137(3):552-7
pubmed: 19880910
Crit Care. 2016 Oct 25;20(1):375
pubmed: 27852281
J Intensive Care. 2016 Aug 11;4:56
pubmed: 27525106
Pediatr Infect Dis J. 2008 Dec;27(12):1103-7
pubmed: 18978518

Auteurs

Frédéric Sangla (F)

Service de Médecine intensive et réanimation, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France.

David Legouis (D)

Service de Soins intensifs adultes, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

Pierre-Emmanuel Marti (PE)

Service de Soins intensifs adultes, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

Sebastian D Sgardello (SD)

Service de Soins intensifs adultes, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

Amélie Brebion (A)

Laboratoire de Virologie, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France.

Pierre Saint-Sardos (P)

Laboratoire de Bactériologie, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France.

Mireille Adda (M)

Service de Médecine intensive et réanimation, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France.

Alexandre Lautrette (A)

Service de Médecine intensive et réanimation, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France.

Bruno Pereira (B)

Département de Biostatistique, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France.

Bertrand Souweine (B)

Service de Médecine intensive et réanimation, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH